JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Search

Smith & Nephew PLC ADR

Geschlossen

32.11 1.71

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

31.57

Max

32.26

Schlüsselkennzahlen

By Trading Economics

Einkommen

35M

331M

Verkäufe

203M

3.2B

KGV

Branchendurchschnitt

23.923

60.328

Dividendenrendite

2.29

Gewinnspanne

10.368

Angestellte

16,988

EBITDA

133M

856M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+1.36% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.29%

2.24%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-578M

15B

Vorheriger Eröffnungskurs

30.4

Vorheriger Schlusskurs

32.11

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Smith & Nephew PLC ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Apr. 2026, 23:15 UTC

Wichtige Nachrichtenereignisse

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27. Apr. 2026, 23:08 UTC

Ergebnisse
Wichtige Markttreiber

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27. Apr. 2026, 23:58 UTC

Ergebnisse

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27. Apr. 2026, 23:58 UTC

Ergebnisse

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27. Apr. 2026, 23:56 UTC

Ergebnisse

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27. Apr. 2026, 23:56 UTC

Ergebnisse

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27. Apr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27. Apr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27. Apr. 2026, 23:34 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27. Apr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27. Apr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27. Apr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. Apr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27. Apr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27. Apr. 2026, 22:10 UTC

Ergebnisse

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27. Apr. 2026, 22:09 UTC

Ergebnisse

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27. Apr. 2026, 21:56 UTC

Ergebnisse

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27. Apr. 2026, 21:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27. Apr. 2026, 21:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27. Apr. 2026, 21:44 UTC

Ergebnisse

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27. Apr. 2026, 21:43 UTC

Ergebnisse

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27. Apr. 2026, 21:41 UTC

Ergebnisse

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27. Apr. 2026, 21:41 UTC

Ergebnisse

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27. Apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

27. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27. Apr. 2026, 20:39 UTC

Ergebnisse

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Peer-Vergleich

Kursveränderung

Smith & Nephew PLC ADR Prognose

Kursziel

By TipRanks

1.36% Vorteil

12-Monats-Prognose

Durchschnitt 32 USD  1.36%

Hoch 32 USD

Tief 32 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Smith & Nephew PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

26.64 / 28.37Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat